Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Sci. Signal., 16 June 2009
Vol. 2, Issue 75, p. re4
[DOI: 10.1126/scisignal.275re4]

REVIEWS

The Vitamin D Sterol–Vitamin D Receptor Ensemble Model Offers Unique Insights into Both Genomic and Rapid-Response Signaling

Mathew T. Mizwicki1* and Anthony W. Norman1,2

1 Department of Biochemistry, University of California, Riverside, CA 92521, USA.
2 Division of Biomedical Sciences, University of California, Riverside, CA 92521, USA.

Gloss: Vitamin D3 was discovered 90 years ago as a dietary agent that prevented the bone disease rickets. Subsequently, it was learned that vitamin D3 itself is biologically inert and only generates biological effects through participation in a two-step metabolic process that generates the steroid hormone 1{alpha},25-dihydroxyvitamin D3 [1{alpha},25(OH)2D3 or 1,25D]. Binding of 1,25D to its vitamin D receptor (VDR) results in various biological responses. The VDR is present in 37 tissues of the body, where it has been shown to function in five physiological systems in addition to the intestine and bone (where it plays a critical role in calcium homeostasis). In these target tissues, the VDR functions both in the cell nucleus (as a transcriptional factor to regulate genes containing a vitamin D response element) and at or near the plasma membrane (as a mediator of rapid signal transduction pathways). Here, we discuss the evidence supporting a vitamin D sterol–VDR conformational ensemble model, whereby different shapes of the 1,25D hormone bind to two different ligand-binding pockets of a flexible VDR to selectively modulate either genomic or rapid responses.

* Corresponding author. E-mail, mathew.mizwicki{at}ucr.edu

Citation: M. T. Mizwicki, A. W. Norman, The Vitamin D Sterol–Vitamin D Receptor Ensemble Model Offers Unique Insights into Both Genomic and Rapid-Response Signaling. Sci. Signal. 2, re4 (2009).


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Vitamin D deficiency may be a risk factor for recurrent pregnancy losses by increasing cellular immunity and autoimmunity.
K. Ota, S. Dambaeva, A.-R. Han, K. Beaman, A. Gilman-Sachs, and J. Kwak-Kim (2014)
Hum. Reprod. 29, 208-219
   Abstract »    Full Text »    PDF »
Nuclear Receptors and Their Selective Pharmacologic Modulators.
T. P. Burris, L. A. Solt, Y. Wang, C. Crumbley, S. Banerjee, K. Griffett, T. Lundasen, T. Hughes, and D. J. Kojetin (2013)
Pharmacol. Rev. 65, 710-778
   Abstract »    Full Text »    PDF »
Relevance of vitamin D in reproduction.
J. Luk, S. Torrealday, G. Neal Perry, and L. Pal (2012)
Hum. Reprod. 27, 3015-3027
   Abstract »    Full Text »    PDF »
Optimal Serum Calcidiol Concentration for Cancer Prevention.
P. TUOHIMAA and Y.- R. LOU (2012)
Anticancer Res 32, 373-381
   Abstract »    Full Text »    PDF »
Vitamin D Deficiency Promotes Skeletal Muscle Hypersensitivity and Sensory Hyperinnervation.
S. E. Tague, G. L. Clarke, M. K. Winter, K. E. McCarson, D. E. Wright, and P. G. Smith (2011)
J. Neurosci. 31, 13728-13738
   Abstract »    Full Text »    PDF »
Requirements for Vitamin D Across the Life Span.
W. B. Grant and B. J. Boucher (2011)
Biol Res Nurs 13, 120-133
   Abstract »    PDF »
Intestinal Cell Calcium Uptake and the Targeted Knockout of the 1,25D3-MARRS (Membrane-associated, Rapid Response Steroid-binding) Receptor/PDIA3/Erp57.
I. Nemere, N. Garbi, G. J. Hammerling, and R. C. Khanal (2010)
J. Biol. Chem. 285, 31859-31866
   Abstract »    Full Text »    PDF »
Plasma 25-Hydroxyvitamin D and Regulation of the Renin-Angiotensin System in Humans.
J. P. Forman, J. S. Williams, and N. D. L. Fisher (2010)
Hypertension 55, 1283-1288
   Abstract »    Full Text »    PDF »
On the Mechanism Underlying (23S)-25-Dehydro-1{alpha}(OH)-vitamin D3-26,23-lactone Antagonism of hVDRwt Gene Activation and Its Switch to a Superagonist.
M. T. Mizwicki, C. M. Bula, P. Mahinthichaichan, H. L. Henry, S. Ishizuka, and A. W. Norman (2009)
J. Biol. Chem. 284, 36292-36301
   Abstract »    Full Text »    PDF »

To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882